Publications

5530 Results

Randomized Phase II/III Study of R-CHOP +/- Venetoclax in Previously Untreated MYC/BCL2 Double Expressor Diffuse Large B Cell Lymphoma (DLBCL): Alliance A051701

Authors
J Abramson;S Geyer;L Pederson;S Giri;E Hsi;R Little;S Gore;D Landsburg;H Cherng;B Kahl;JW Friedberg;N Bartlett;J Leonard
Journal / Conference
ASCO Annual Meeting (May 31 - June 4, 2024, Chicago, IL ), Rapid Oral Abstract Session; J Clin Oncol 42, 2024 (suppl 16; abstr 7012)
Year
2024
Research Committee(s)
Lymphoma
Study Number(s)
CTSU/A051701

Alliance A091902: A multicenter randomized phase II trial of paclitaxel (P) with or without nivolumab (N) in patients (pts) with advanced angiosarcoma (AS)

Authors
J Grilley Olson;J Allred;S Schuetze;E Davis;A Poklepovic;M Wagner;R Riedel;A Hartranft;M Xu-Welliver;S Berg;S George;S Robinson;P Googe;S DAngelo;G Schwartz
Journal / Conference
ASCO Annual Meeting (May 31 - June 4, 2024, Chicago, IL ), Rapid Oral Abstract Session; J Clin Oncol 42, 2024 (suppl 16; abstr 11514)
Year
2024

Undetectable measurable residual disease (MRD) is associated with improved long-term outcome in patients with follicular lymphoma (FL) treated with chemo-immunotherapy: results from SWOG S0016

Authors
A Danilov;H Li;M Shadman;L Rimsza;A Zebari;S Smith;M LeBlanc;JW Friedberg;C Carlson;J Song
Journal / Conference
European Hematology Association Hybrid Congress (June 13-16, Madrid Spain), poster
Year
2024
Research Committee(s)
Lymphoma
Study Number(s)
S0016

Clinical and molecular characterization of AXL in colorectal cancer: CALGB (Alliance)/SWOG 80405 and real-world data

Authors
K Ashouri;Y Yan;J Millstein;S Soni;S Algaze;P Mittal;A Wong;J Lo;L Torres-Gonzalez;P Jayachandran;W Zhang;A Meyer;F Battaglin;H-J Lenz
Journal / Conference
ASCO Annual Meeting (May 31 - June 4, 2024, Chicago, IL ), poster; J Clin Oncol 42, 2024 (suppl 16; abstr 3145)
Year
2024
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Association of Higher baseline stress and pain associated with clinical outcomes: A secondary analysis from Alliance A011502

Authors
S Gandhi;K Ballman;M Holmes;K Visvanathan;B Symington;M Carvan;C Matyka;A Weiss;E Winer;L Carey;A Partridge;W Chen
Journal / Conference
ASCO Annual Meeting (May 31 - June 4, 2024, Chicago, IL ), Rapid Oral Abstract Session; J Clin Oncol 42, 2024 (suppl 16; abstr 11016)
Year
2024
Research Committee(s)
Breast
Study Number(s)
CTSU/A011502

Correlation of Stress, depression, sleep, and pain vary with race and BMI: Secondary analysis from A011502

Authors
S Gandhi;K Ballman;M Holmes;K Visvanathan;B Symington;M Carvan;C Matyka;A Weiss;E Winer;L Carey;A Partridge;W Chen
Journal / Conference
ASCO Annual Meeting (May 31 - June 4, 2024, Chicago, IL ), publication only; J Clin Oncol 42, 2024 (suppl 16; abstr e23171)
Year
2024
Research Committee(s)
Breast
Study Number(s)
CTSU/A011502

SWOG S1011 – Subgroup analysis of the Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer

Authors
S Lerner;C Tangen;R Svatek;S Daneshmand;K Pohar;E Skinner;A Schuckman;A Sagalowsky;N Smith;A Kamat;W Kassouf;M Plets;R Bangs;T Koppie;A Alva;F La Rosa;S Pal;A Kibel;D Canter;I Thompson
Journal / Conference
AUA Annual Meeting (May 3-6, 2024, San Antonio, TX);THE JOURNAL OF UROLOGY Vol. 211, No. 5S2, Supplement, Friday, May 3, 2024
Year
2024
Research Committee(s)
Genitourinary
Study Number(s)
S1011

Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer

Authors
M Chavez MacGregor;J Miao;L Pusztai;M Goetz;P Rastogi;P Ganz;E Mamounas;S Paik;H Bandox;W Razaq;A O'Dea;V Kaklamani;A Silber;L Flaum;E Andreopoulou;A Wendt;J Carney;P Sharma;J Gralow;D Lew;W Barlow;G Hortobagyi
Journal / Conference
Journal of Clinical Oncology Jun 4:JCO2302344. doi: 10.1200/JCO.23.02344. Online ahead of print
Year
2024
Research Committee(s)
Breast
Study Number(s)
S1207

Pediatric and Adolescent Hodgkin Lymphoma: Paving the Way for Standards of Care and Shared Decision Making

Authors
J Kahn;C Mauz-Korholz;T Hernandez;S Milgrom;S Castellino
Journal / Conference
ASCO Educational Book
Year
2024
Research Committee(s)
Lymphoma
Study Number(s)
S1826

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: Adrenocortical Carcinoma Cohort

Authors
S Patel;M Othus;Y Chae;T Huynh;B Tan;T Kuzel;N Vogelzang;C McLeod;G Lopez;H Chen;E Sharon;H Streicher;C Ryan;C Blanke;R Kurzrock
Journal / Conference
Journal for ImmunoTherapy of Cancer (JITC) Jul 27;12(7):e009074
Year
2024
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID39067873
PMC
PMC11284838
Study Number(s)
S1609